Last year, we looked at Phase II clinical trials of MK-0974, an investigational oral calcitonin gene-related pepitide (CGRP) receptor antagonist, a new type of Migraine abortive. That medication has now been named telcagepant, and is showing great promise as a new Migraine abortive. When I spoke with lead researcher, Dr. Tony Ho, last year, he commented "MK-0974 has a novel new mechanism for relief. Nearly 70% get pain relief at two hours. The results are excellent for sustained relief at...
Full Question: I first started suffering with migraines when I was 30 years old. They always begin with a visual aura and when I was... Read more »
Full Question: What are the causes of migraine?Please help. Need to know what are the causes of migraine? Is there other way to cure... Read more »
A study published in the July 22, 2008, issue of Neurology®, indicates that taking the neuronal stabilizing agent (epilepsy drug) Topamax... Read more »
Full Question: I have been on Topamax for menstrual migraine for 18 months and it has literally saved my life. My bi-monthly migraines are... Read more »
Full Question: What are the effects on the brain when a patient has migraine disease? Disha. Answer: Dear Disha; The truth is... Read more »
It is a good idea to type and print your migraine diary before you see your doctor in order to keep it legible and clean. If you arrive prepared,... Read more »
Study results are again indicating that Migraineurs who experience frequent Migraine attacks and / or have a long history of Migraines are at... Read more »
Migraine awareness is high, and recent medical research indicates that migraines are caused by inherited mutations in genes which control brain... Read more »
A reader asks experts at InteliHealth if it's common for migraine sufferers to experience memory loss during the headaches. Dr. Lori Tishler responds... Read more »
A study published in the July 22, 2008, issue of Neurology®, indicates that taking the neuronal stabilizing agent (epilepsy drug) Topamax... Read more »